NewLink Genetics Corporation Company Profile (NASDAQ:NLNK)

About NewLink Genetics Corporation

NewLink Genetics Corporation logoNewLink Genetics Corporation is a biopharmaceutical company focused on discovering, developing and commercializing immunotherapeutic products for cancer treatment. The Company's portfolio includes biologic and small-molecule immunotherapy product candidates for a range of oncology indications. Its biologic product candidates are based on its HyperAcute immunotherapy technology platform, which is designed to stimulate the human immune system. Algenpantucel-L is its clinically advanced product candidate for patients with pancreatic cancer. Its additional HyperAcute cellular HyperAcute Cellular Immunotherapy product candidates in clinical development include tergenpumatucel-L and dorgenmeltucel-L for patients with advanced lung cancer and melanoma. It has two small-molecule product candidates in clinical development: GDC-0919 and indoximod. These product candidates are indoleamine-2, 3-dioxygenase (IDO) pathway inhibitors and focus on breaking the immune system's tolerance to cancer.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: NLNK
  • CUSIP: 65151110
Key Metrics:
  • Previous Close: $14.40
  • 50 Day Moving Average: $12.58
  • 200 Day Moving Average: $12.10
  • 52-Week Range: $9.23 - $23.80
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -9.80
  • P/E Growth: 0.00
  • Market Cap: $419.53M
  • Outstanding Shares: 29,134,000
  • Beta: 1.12
Profitability:
  • Net Margins: -303.49%
  • Return on Equity: -56.48%
  • Return on Assets: -47.55%
Debt:
  • Current Ratio: 4.41%
  • Quick Ratio: 4.41%
Additional Links:
Companies Related to NewLink Genetics Corporation:

Analyst Ratings

Consensus Ratings for NewLink Genetics Corporation (NASDAQ:NLNK) (?)
Ratings Breakdown: 2 Hold Ratings, 4 Buy Ratings
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $25.33 (75.93% upside)

Analysts' Ratings History for NewLink Genetics Corporation (NASDAQ:NLNK)
Show:
DateFirmActionRatingPrice TargetDetails
11/3/2016Jefferies Group LLCReiterated RatingHold$12.00View Rating Details
5/16/2016Robert W. BairdReiterated RatingBuyView Rating Details
5/10/2016SunTrust Banks, Inc.DowngradeBuy -> Neutral$59.00 -> $12.00View Rating Details
5/10/2016MizuhoLower Price TargetBuy$52.00 -> $20.00View Rating Details
5/10/2016Stifel NicolausLower Price TargetBuy$63.00 -> $23.00View Rating Details
4/29/2016Cantor FitzgeraldReiterated RatingBuy$62.00View Rating Details
(Data available from 2/22/2015 forward)

Earnings

Earnings History for NewLink Genetics Corporation (NASDAQ:NLNK)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/27/2017        
11/1/2016Q3($0.60)($0.54)$3.83 million$15.35 millionViewN/AView Earnings Details
7/29/2016Q216($0.77)($1.12)$5.41 millionViewListenView Earnings Details
4/29/2016Q116($1.70)($0.82)$2.08 million$4.34 millionViewListenView Earnings Details
2/29/2016Q415($0.92)($0.75)$4.89 million$6.06 millionViewListenView Earnings Details
11/3/2015Q315($0.66)($0.55)$6.76 millionViewN/AView Earnings Details
7/31/2015Q215($0.70)($0.49)$4.32 million$7.45 millionViewListenView Earnings Details
5/5/2015Q115($0.22)$0.35$2.32 millionViewN/AView Earnings Details
2/26/2015Q414($0.68)$4.05$2.98 million$159.25 millionViewN/AView Earnings Details
11/6/2014Q314($0.40)($0.20)$2.80 millionViewN/AView Earnings Details
8/5/2014Q214($0.42)($0.33)ViewN/AView Earnings Details
5/6/2014($0.37)($0.33)ViewN/AView Earnings Details
3/11/2014($0.37)($0.31)ViewN/AView Earnings Details
11/11/2013Q3($0.33)($0.32)ViewN/AView Earnings Details
8/7/2013Q213($0.32)($0.28)$0.59 million$0.23 millionViewN/AView Earnings Details
5/6/2013Q113($0.28)($0.33)$0.41 million$0.30 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for NewLink Genetics Corporation (NASDAQ:NLNK)
Current Year EPS Consensus Estimate: $-3.09 EPS
Next Year EPS Consensus Estimate: $-1.47 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.92)($0.87)($0.90)
Q2 20162($0.89)($0.80)($0.85)
Q3 20162($0.84)($0.69)($0.77)
Q4 20162($0.87)($0.59)($0.73)
Q1 20171($0.43)($0.43)($0.43)
Q2 20171($0.86)($0.86)($0.86)
Q3 20171($0.43)($0.43)($0.43)
Q4 20171($0.43)($0.43)($0.43)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for NewLink Genetics Corporation (NASDAQ:NLNK)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for NewLink Genetics Corporation (NASDAQ:NLNK)
Insider Ownership Percentage: 12.00%
Institutional Ownership Percentage: 46.83%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/15/2016Charles J Jr. LinkCEOSell25,000$17.86$446,500.00View SEC Filing  
1/6/2016Charles J. Jr. LinkCEOSell25,000$32.53$813,250.00View SEC Filing  
1/5/2016Brian WileyVPSell1,295$34.99$45,312.05View SEC Filing  
1/5/2016Carl W. LangreninsiderSell1,095$34.97$38,292.15View SEC Filing  
1/5/2016Charles J. Jr. LinkCEOSell5,001$35.06$175,335.06View SEC Filing  
1/5/2016John B. Henneman IIICFOSell175$35.74$6,254.50View SEC Filing  
10/7/2015Charles J. Jr. LinkCEOSell10,000$35.16$351,600.00View SEC Filing  
10/5/2015Charles J. Jr. LinkCEOSell15,000$37.36$560,400.00View SEC Filing  
7/13/2015Joseph SaluriDirectorSell5,000$50.42$252,100.00View SEC Filing  
7/6/2015Charles J Jr. LinkCEOSell20,000$44.65$893,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for NewLink Genetics Corporation (NASDAQ:NLNK)
DateHeadline
finance.yahoo.com logoNewLink Genetics (NLNK): Moving Average Crossover Alert (NASDAQ:NLNK)
finance.yahoo.com - February 21 at 6:04 PM
nasdaq.com logoNewLink Genetics to Host Its Fourth Quarter and Year End 2016 Financial Results Conference Call on (NASDAQ:NLNK)
www.nasdaq.com - February 20 at 9:51 AM
feeds.benzinga.com logoNewLink Genetics to Host Its Fourth Quarter and Year End 2016 Financial Results Conference Call on February 28, 2017 (NASDAQ:NLNK)
feeds.benzinga.com - February 20 at 9:05 AM
News IconEPS Of NewLink Genetics Corporation (NASDAQ:NLNK) At $-0.66 ... - Stock Observer (NASDAQ:NLNK)
www.thestockobserver.com - February 18 at 11:57 AM
globenewswire.com logoNewLink Genetics to Participate in 2017 SunTrust Orphan Drug Day on February 14th - GlobeNewswire (press release) (NASDAQ:NLNK)
globenewswire.com - February 14 at 1:03 AM
wsj.com logo[$$] Cevec Pharma, NewLink Genetics Target Zika Through Licensing Deal (NASDAQ:NLNK)
www.wsj.com - February 13 at 8:00 PM
finance.yahoo.com logoNewLink Genetics to Participate in 2017 SunTrust Orphan Drug Day on February 14th (NASDAQ:NLNK)
finance.yahoo.com - February 13 at 9:51 AM
nasdaq.com logoWill NewLink Genetics (NLNK) Continue to Surge Higher? - Nasdaq - Nasdaq (NASDAQ:NLNK)
www.nasdaq.com - February 11 at 11:57 PM
finance.yahoo.com logoWill NewLink Genetics (NLNK) Continue to Surge Higher? (NASDAQ:NLNK)
finance.yahoo.com - February 10 at 5:59 AM
finance.yahoo.com logoLifshitz & Miller Law Firm Announces Investigation of DaVita Inc., First NBC Bank Holdings Company, Fresenius Medical Care AG & Co. KGAA, Inotek Pharmaceuticals Corporation, Natural Health Trends Corp., NeoPhotonics Corporation, NewLink Gen (NASDAQ:NLNK)
finance.yahoo.com - February 6 at 6:57 PM
News IconNews Impact Score Of NewLink Genetics Corporation (NASDAQ:NLNK) At 100 - Stock Observer (NASDAQ:NLNK)
www.thestockobserver.com - February 3 at 1:05 AM
News IconTrading Scope: Checking on Shares of NewLink Genetics Corporation (NASDAQ:NLNK) - The Tribune (NASDAQ:NLNK)
lakecitytribune.com - January 31 at 12:34 AM
News IconHigh Volatility Moving the Needle For Shares of NewLink Genetics Corporation (NASDAQ:NLNK) - Wall Street Beacon (NASDAQ:NLNK)
wsbeacon.com - January 31 at 12:34 AM
News IconInvesting Focus: Indicators in View on Shares of NewLink Genetics Corporation (NLNK) - Market Point (NASDAQ:NLNK)
mtptnews.com - January 31 at 12:34 AM
News IconStock Tracker: Looking at the Numbers for NewLink Genetics Corporation (NASDAQ:NLNK) - The Tribune (NASDAQ:NLNK)
lakecitytribune.com - January 28 at 6:58 PM
News IconNewLink Genetics Corporation (NASDAQ:NLNK) Quarterly EPS Projection At $-0.66 - Stock Observer (NASDAQ:NLNK)
www.thestockobserver.com - January 28 at 6:58 PM
News IconStock Focus: Watching RSI Levels on Shares of NewLink Genetics Corporation (NLNK) - Market Point (NASDAQ:NLNK)
mtptnews.com - January 27 at 4:24 AM
4-traders.com logoNewLink Genetics : Law firms open investigations into NewLink (NASDAQ:NLNK)
www.4-traders.com - January 25 at 10:01 PM
News IconNASDAQ:NLNK Investor News: Investigation of potential Wrongdoing at NewLink Genetics Corp (NASDAQ:NLNK)
www.groundreport.com - January 23 at 7:08 PM
News IconWall Street Holds Inauguration Gains, How Did This Stock Fare: NewLink Genetics Corporation (NASDAQ:NLNK) - Wall Street Beacon (NASDAQ:NLNK)
wsbeacon.com - January 21 at 11:39 PM
News IconInvestors are Looking at Levels for NewLink Genetics Corporation (NLNK) - Sherwood Daily (NASDAQ:NLNK)
sherwooddaily.com - January 20 at 7:37 PM
News IconStock Momentum Skidding to a Halt For NewLink Genetics Corporation (NASDAQ:NLNK) - Wall Street Beacon (NASDAQ:NLNK)
wsbeacon.com - January 18 at 12:18 AM
News IconInvestigation for Long-Term Investors in Shares of NewLink Genetics Corp (NASDAQ:NLNK) Announced (NASDAQ:NLNK)
www.ssuchronicle.com - January 16 at 7:23 PM
News IconWill The Needle Move For NewLink Genetics Corporation (NASDAQ:NLNK) Shares This Earnings Season? - Wall Street Beacon (NASDAQ:NLNK)
wsbeacon.com - January 12 at 7:27 PM
News IconStock Reaching Most Volatile List Today: NewLink Genetics Corporation (NASDAQ:NLNK) - Wall Street Beacon (NASDAQ:NLNK)
wsbeacon.com - January 11 at 7:26 PM
News IconStock Getting Tripped Up In Session: NewLink Genetics Corporation (NASDAQ:NLNK) - Wall Street Beacon (NASDAQ:NLNK)
wsbeacon.com - January 11 at 7:26 PM
capitalcube.com logoNewLink Genetics Corp. – Value Analysis (NASDAQ:NLNK) : January 11, 2017 (NASDAQ:NLNK)
www.capitalcube.com - January 11 at 7:26 PM
businesswire.com logoNewman Ferrara LLP Announces Corporate Governance Investigation of NewLink Genetics Corporation - Business Wire (press release) (NASDAQ:NLNK)
www.businesswire.com - January 10 at 8:57 AM
capitalcube.com logoNewLink Genetics Corp. breached its 50 day moving average in a Bullish Manner : NLNK-US : January 10, 2017 (NASDAQ:NLNK)
www.capitalcube.com - January 10 at 8:57 AM
News IconNotable Monday Option Activity: NLNK, MSM, EXAS (NASDAQ:NLNK)
www.stockoptionschannel.com - January 9 at 7:34 PM
News IconNewLink Genetics Corp NLNK Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NASDAQ:NLNK)
www.bioportfolio.com - January 9 at 7:34 PM
finance.yahoo.com logoNewman Ferrara LLP Announces Corporate Governance Investigation of NewLink Genetics Corporation (NASDAQ:NLNK)
finance.yahoo.com - January 9 at 7:34 PM
investornewswire.com logoNewLink Genetics Corporation (NASDAQ:NLNK) Records An Impact Score Of 100 - Investor Newswire (NASDAQ:NLNK)
www.investornewswire.com - January 5 at 8:42 PM
biz.yahoo.com logoNEWLINK GENETICS CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibit (NASDAQ:NLNK)
biz.yahoo.com - January 5 at 8:42 PM
News IconNewLink Genetics Corporation (NASDAQ:NLNK) News Impact Score At 100 - Stock Observer (NASDAQ:NLNK)
www.thestockobserver.com - January 4 at 7:39 PM
News IconReady for an Upsurge? Analysts Chime in on NewLink Genetics Corporation (NASDAQ:NLNK) - Prospect Journal (NASDAQ:NLNK)
prospectjournal.com - January 2 at 6:42 PM
News IconNewLink Genetics Corporation (NASDAQ:NLNK) EPS At $-0.66 - Stock Observer (NASDAQ:NLNK)
www.thestockobserver.com - December 31 at 8:56 AM
seekingalpha.com logoNewLink Genetics: A Classic Value Catalyst Buy - Seeking Alpha - Seeking Alpha (NASDAQ:NLNK)
seekingalpha.com - December 30 at 7:58 AM
News IconNewLink Genetics Corporation (NASDAQ:NLNK) News Impact Score At 83 - Stock Observer (NASDAQ:NLNK)
www.thestockobserver.com - December 28 at 11:45 PM
capitalcube.com logoETFs with exposure to NewLink Genetics Corp. : December 27, 2016 (NASDAQ:NLNK)
www.capitalcube.com - December 27 at 6:43 PM
finance.yahoo.com logoNewLink Genetics (NLNK) Jumps: Stock Adds 10% in Session (NASDAQ:NLNK)
finance.yahoo.com - December 27 at 10:04 AM
stocksdaily.net logoCan NewLink Genetics Corporation (NASDAQ:NLNK) Post EPS Of $-0.66? - Stocks Daily (NASDAQ:NLNK)
www.stocksdaily.net - December 25 at 6:11 PM
feeds.benzinga.com logoWhere Does Merck's Ebola Vaccine Breakthrough Leave Competitors? (NASDAQ:NLNK)
feeds.benzinga.com - December 23 at 4:44 PM
seekingalpha.com logoMerck's Ebola vaccine candidate shows encouraging effect in Guinea-based study; licensor NewLink Genetics up 8% (NASDAQ:NLNK)
seekingalpha.com - December 23 at 12:28 PM
investornewswire.com logoSentiments And Ratings Alert: NewLink Genetics Corporation (NASDAQ:NLNK) - Investor Newswire (NASDAQ:NLNK)
www.investornewswire.com - December 22 at 7:07 PM
News IconCCI, ADX, and Williams %R Review for NewLink Genetics Corporation (NLNK) - StockTalk Daily (NASDAQ:NLNK)
stocktalkdaily.com - December 22 at 6:47 AM
News IconNews Impact Score Of NewLink Genetics Corporation (NASDAQ:NLNK) At 83 - Stock Observer (NASDAQ:NLNK)
www.thestockobserver.com - December 22 at 6:47 AM
News IconMarket Focus: Checking Up on Shares of NewLink Genetics Corporation (NASDAQ:NLNK) - OIB News (NASDAQ:NLNK)
oibnews.com - December 21 at 11:13 AM
insidermonkey.com logoDo Hedge Funds Love Western Asset Mortgage Capital Corp (WMC)? (NASDAQ:NLNK)
www.insidermonkey.com - December 21 at 11:13 AM
News IconStock Concentration on Shares of NewLink Genetics Corporation (NASDAQ:NLNK) - OIB News (NASDAQ:NLNK)
oibnews.com - December 20 at 12:48 PM

Social

What is NewLink Genetics Corporation's stock symbol?

NewLink Genetics Corporation trades on the NASDAQ under the ticker symbol "NLNK."

Where is NewLink Genetics Corporation's stock going? Where will NewLink Genetics Corporation's stock price be in 2017?

6 equities research analysts have issued 1-year target prices for NewLink Genetics Corporation's shares. Their forecasts range from $12.00 to $62.00. On average, they anticipate NewLink Genetics Corporation's share price to reach $25.33 in the next twelve months.

When will NewLink Genetics Corporation announce their earnings?

NewLink Genetics Corporation is scheduled to release their next quarterly earnings announcement on Monday, February, 27th 2017.

Who owns NewLink Genetics Corporation stock?

NewLink Genetics Corporation's stock is owned by many different of retail and institutional investors. Top institutional investors include Orbimed Advisors LLC (6.84%), FMR LLC (3.11%), Franklin Resources Inc. (1.77%), State Street Corp (1.48%), Bogle Investment Management L P DE (0.60%) and Renaissance Technologies LLC (0.50%). Company insiders that own NewLink Genetics Corporation stock include Brian Wiley, Carl W Langren, Charles J Jr Link, John B Henneman III and Joseph Saluri.

Who sold NewLink Genetics Corporation stock? Who is selling NewLink Genetics Corporation stock?

NewLink Genetics Corporation's stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Bogle Investment Management L P DE, Federated Investors Inc. PA and Wall Street Associates.

Who bought NewLink Genetics Corporation stock? Who is buying NewLink Genetics Corporation stock?

NewLink Genetics Corporation's stock was bought by a variety of institutional investors in the last quarter, including FMR LLC, Northwest Wealth Management LLC, Orbimed Advisors LLC, A.R.T. Advisors LLC, State Street Corp, Dimensional Fund Advisors LP, GSA Capital Partners LLP and Trexquant Investment LP.

How do I buy NewLink Genetics Corporation stock?

Shares of NewLink Genetics Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of NewLink Genetics Corporation stock cost?

One share of NewLink Genetics Corporation stock can currently be purchased for approximately $14.40.

NewLink Genetics Corporation (NASDAQ:NLNK) Chart for Wednesday, February, 22, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for NewLink Genetics Corporation (NASDAQ:NLNK)

Earnings History Chart

Earnings by Quarter for NewLink Genetics Corporation (NASDAQ:NLNK)

Dividend History Chart

Dividend Payments by Quarter for NewLink Genetics Corporation (NASDAQ:NLNK)

Last Updated on 2/22/2017 by MarketBeat.com Staff